YOLFTbeta
Universal Biosensors Inc

Universal Biosensors Inc

UBI · AU · Healthcare / Medical Devices

0.014AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.014
Open0.014
Day Range0.014 – 0.014
52-Week Range0.014 – 0.014
Volume0
Market Cap4.17M
P/E (TTM)0.00
Forward P/E11.29
EPS-0.06
Dividend Yield0.00%
Beta0.21
50-Day Avg0.014
200-Day Avg0.014

About

Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO2, malic acid, glucose, fructose, total acid, and titratable acidity. It also provides non-diagnostic laboratory services and coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans. Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Salesh Balak B.A., C.A.
  • Employees76
  • Headquarters1 Corporate Avenue, Rowville, VIC, Australia, 3178, Australia
  • Websitehttps://www.universalbiosensors.com

Leadership

  • Mr. Salesh Balak B.A., C.A.Company Secretary & Corporate Advisor · b. 1969
  • Mr. Peter George MullinMD, Finance Director, CFO, Company Secretary & Executive Director · b. 1970
  • Mr. Luke Cossins B.Sc., M.B.A.C.T.O
  • Mr. Keith SimsGlobal Marketing Director
  • Ms. Ann Chew B.Com., CPA, CIAHead of People Strategy & Culture

Financials

Income Statement

Currency: AUD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue750.00K1.00M1.82M2.55M2.65M1.29M4.56M22.04M18.18M14.70M29.65M15.09M9.53M16.77M18.83M25.19M69.46M6.90M3.20M5.78M4.52M6.63M6.28M
Growth (%)-+33.33%+81.70%+40.40%+4.05%-51.26%+252.30%+383.68%-17.52%-19.16%+101.73%-49.10%-36.85%+76.03%+12.26%+33.78%+175.72%-90.07%-53.57%+80.41%-21.68%+46.58%-5.28%
Cost of Revenue439.00K875.00K1.48M--2.33M3.12M627.40K8.67M13.02M18.66M11.64M555.83K1.38M1.15M3.95M2.51M3.57M2.58M3.67M2.39M2.35M2.28M
Gross Profit----2.65M-1.04M1.44M21.42M9.51M1.68M10.99M3.45M8.97M15.39M17.68M21.24M66.95M3.33M623.09K2.11M2.14M4.28M4.00M
Gross Margin----100.00%-80.22%31.50%97.15%52.33%11.42%37.07%22.84%94.17%91.77%93.88%84.32%96.38%48.22%19.46%36.44%47.27%64.60%63.70%
Operating Expense----5.78M8.04M15.96M20.78M17.32M17.08M20.27M21.68M22.76M25.79M21.40M20.22M20.52M13.73M10.36M13.09M21.22M20.97M20.97M
Operating Income78.00K----3.12M-9.08M-14.53M630.64K-7.80M-15.41M-9.28M-18.24M-13.79M-10.40M-3.72M1.02M46.42M-10.40M-9.73M-10.99M-19.08M-16.68M-16.97M
Operating Margin10.40%----117.69%-701.56%-318.80%2.86%-42.92%-104.83%-31.31%-120.86%-144.66%-61.98%-19.77%4.03%66.84%-150.78%-303.88%-190.17%-421.63%-251.48%-270.08%
EBITDA-----3.12M-8.24M-9.72M4.29M-7.80M-15.38M-6.49M-8.32M-14.08M-8.41M-1.08M3.61M48.54M-7.46M-7.88M-11.72M-31.66M-9.09M-13.42M
EBITDA Margin-----117.69%-637.20%-213.28%19.47%-42.92%-104.62%-21.91%-55.12%-147.71%-50.12%-5.72%14.31%69.88%-108.11%-246.00%-202.78%-699.67%-137.05%-213.54%
Net Income-----2.94M-8.41M-12.00M1.43M-6.61M-14.69M-9.13M-11.63M-9.32M-6.58M1.25M-764.72K37.56M-4.85M-7.67M-10.30M-26.85M-6.74M-14.24M
Net Income Margin-----110.95%-649.93%-263.23%6.49%-36.36%-99.97%-30.80%-77.10%-97.76%-39.20%6.64%-3.04%54.08%-70.26%-239.40%-178.30%-593.48%-101.64%-226.65%
R&D---2.69M3.28M8.71M11.59M14.90M6.48M9.81M13.48M15.48M17.14M19.76M15.87M10.83M11.58M5.54M5.04M9.28M12.29M4.97M4.15M
R&D as % of Total Revenue---105.57%123.50%673.63%254.22%67.59%35.66%66.77%45.48%102.61%179.82%117.82%84.26%42.99%16.67%80.25%157.52%160.65%271.64%75.00%66.11%
Interest Expense0000009.49K9.64K0029.26K819.77K2.66M3.32M2.90M2.80M2.99M4.79M154.80K121.91K217.52K177.38K102.82K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.21%0.04%0.00%0.00%0.10%5.43%27.93%19.81%15.41%11.13%4.31%69.39%4.83%2.11%4.81%2.67%1.64%

Balance Sheet

Currency: AUD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Assets1.55M4.17M4.23M4.32M39.88M63.86M54.69M56.08M53.84M45.22M49.07M54.62M47.53M44.95M49.99M46.26M69.98M62.66M56.38M44.50M46.15M29.97M25.84M
Total Liabilities192.00K101.00K259.00K384.00K2.84M3.78M5.98M4.77M6.62M10.19M9.69M24.94M27.79M31.70M36.74M33.49M19.30M17.27M18.40M16.89M20.05M10.47M8.47M
Total Equity1.36M4.07M3.97M3.93M37.05M60.07M48.70M51.31M47.22M35.02M39.37M29.68M19.74M13.26M13.25M12.77M50.67M45.39M37.98M27.61M26.09M19.51M17.37M
Cash499.00K3.20M3.23M3.25M31.70M42.19M28.33M31.29M23.27M15.09M23.65M23.74M16.33M14.35M20.40M26.26M11.81M32.29M23.56M15.32M25.98M10.24M8.54M
Total Debt-----------15.86M18.00M20.19M20.66M20.58M--4.16M2.26M4.83M4.97M4.01M
Net Debt-----31.70M-42.19M-28.33M-31.29M-23.27M-15.09M-23.65M-7.88M1.67M5.84M254.13K-7.23M-11.81M-32.29M-19.40M-13.06M-21.15M-5.27M-4.53M

Cash Flow

Currency: AUD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow342.00K-205.00K226.00K-2.33M-9.31M-7.14M5.87M-6.41M-7.16M-3.30M-16.63M-5.41M1.83M7.05M8.69M1.76M33.24M-8.29M-9.90M-14.70M-14.62M-12.30M
Investing Cash Flow-----5.42M-11.97M-6.47M-2.99M-2.32M-1.10M-687.25K-159.44K-947.39K-1.27M-1.27M-1.02M-356.79K-10.28M-372.20K-664.58K-1.57M-1.47M-412.73K
Financing Cash Flow296.00K3.00M-23.00K33.89M32.23M-11.62K79.00K715.30K79.50K12.55M16.34M-1.79M-3.74M45.17K-368.86K-20.95M3.40K43.64K95.62K25.01M-82.84K11.10M
Capital Expenditure101.00K98.00K179.00K210.00K5.42M8.83M9.59M2.99M2.32M1.10M687.25K159.44K955.33K1.27M1.21M1.29M448.87K10.31M387.05K664.58K1.57M1.47M412.73K
Free Cash Flow-----7.75M-18.15M-16.74M2.88M-8.73M-8.26M-3.99M-16.79M-6.37M559.13K5.84M7.40M1.32M22.93M-8.68M-10.56M-16.27M-16.09M-12.71M
Dividends Paid---------------------29.58K-
FCF to OCF----331.96%194.80%234.38%49.04%136.17%115.41%120.82%100.96%117.65%30.56%82.80%85.13%74.56%68.99%104.67%106.72%110.65%110.08%103.36%
Dividend Paid to FCF----------------------0.18%-

Earnings

Report DateJun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Oct 30, 2009Feb 24, 2010May 13, 2010Aug 9, 2010Oct 26, 2010Feb 24, 2011May 5, 2011Aug 9, 2011Nov 3, 2011Mar 13, 2012May 2, 2012Aug 7, 2012Oct 29, 2012Feb 14, 2013May 2, 2013Aug 1, 2013Oct 30, 2013Feb 13, 2014Apr 24, 2014Jul 31, 2014Oct 30, 2014Feb 19, 2015Apr 23, 2015Jul 23, 2015Oct 29, 2015Feb 19, 2016Apr 21, 2016Jul 21, 2016Oct 20, 2016Mar 22, 2017May 4, 2017Aug 7, 2017Oct 24, 2017Mar 20, 2018Apr 27, 2018Aug 13, 2018Oct 30, 2018Feb 22, 2019Apr 30, 2019Jul 25, 2019Nov 4, 2019Feb 26, 2020Apr 24, 2020Jul 24, 2020Oct 29, 2020Feb 24, 2021Apr 30, 2021Aug 6, 2021Oct 29, 2021Feb 24, 2022Apr 29, 2022Aug 10, 2022Oct 27, 2022Feb 24, 2023Apr 28, 2023Feb 26, 2025May 12, 2025Jul 31, 2025
EPS Estimate------------------------------------------------------0.00--0.02--0.050.00----0.000.00-
EPS Actual-0.02-0.02-0.02-0.01-0.02-0.01-0.04-0.01-0.03-0.030.08-0.01-0.02-0.01-0.01-0.02-0.03-0.02-0.02-0.02-0.01-0.01-0.03-0.03-0.02-0.00-0.02-0.02-0.02-0.01-0.00-0.02-0.01-0.00-0.01-0.010.00-0.010.030.010.00-0.01-0.010.00-0.000.24-0.02-0.01-0.01-0.00-0.00-0.01-0.02-0.01-0.01-0.01-0.01-0.02-0.02-0.03-0.02-0.02-0.06-0.02-0.01-0.01-0.02
Surprise--------------------------------------------------------57.08%-56.99%--------
Timing------------------------------------------------------------Pre-marketAfter-hoursAfter-hoursAfter-hours--Pre-market

Key Statistics & Ratios

Market Cap4.17M
Enterprise Value5.02M
Trailing P/E0.00
Forward P/E11.29
PEG Ratio0.16
Price / Sales0.70
Price / Book0.59
EPS-0.06
Book Value0.024
Revenue (TTM)5.95M
Gross Profit (TTM)1.59M
EBITDA-19.34M
Profit Margin-293.32%
Operating Margin-554.66%
Return on Equity-110.97%
Return on Assets-52.10%
Shares Outstanding298.07M
Shares Float171.46M
Beta0.21
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%